![]() |
Acta Pharmacologica Sinica (2009) 30: 1344–1350; doi: 10.1038/aps.2009.118; published online 24 August 2009 |
| Original Article | [ Full text ] |
| Derivatives of (phenylsulfonamido-methyl)nicotine and (phenylsulfonamido-methyl)thiazole as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors: synthesis and biological activities in vitro
|
Xu ZHANG#, Yang ZHOU#, Yu SHEN, Li-li DU, Jun-hua CHEN, Ying LENG*, Jian-hua SHEN* |
State Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica,
|
Methods: Our initial
lead 4-(phenylsulfonamido-methyl)benzamides were modified. Inhibition of human and mouse 11β-HSD1
enzymatic activities by the new compounds was determined by a scintillation proximity assay (SPA) using microsomes containing 11β-HSD1.
Results: Sixteen new compounds (
Conclusion: This study
provides two promising new templates for 11β-HSD1 inhibitors.
|
Keywords:
|
We gratefully acknowledge financial support from
the National Basic Research Program of China (973 Program, 2009CB522300) and
the National Natural Science Foundation of China (Grant 90813029). The project was also supported by the
Science and Technology Commission of Shanghai Municipality (Grants 08QH14028
and 08ZR1422600).
|
|
[ Full text ] |
Copyright©APS 2009 Add: 294 Tai-Yuan Road, Shanghai 200031, China Phn: 86-21-5492-2821 Fax: 86-21-5492-2823 E-mail: aps@mail.shcnc.ac.cn |